-transparent.png){kind=logo}
Bonnecor treatment proved effective in arrest of ectopic excitation and is well tolerated by patients with acute myocardial infarction (AMI) and chronic coronary disease (CCD). Neither decline of arterial pressure nor inhibition of intracardiac hemodynamics was recorded. The main side effect manifested as prolongation of PQ interval. Bonnecor can be widely introduced in the treatment and prevention of extrasystolic arrhythmias in AMI and CCD patients.
Related Publications
L I Ol'binskaia, and
M A Rybakov, and
Zh M Sizova
December 1990,
Kardiologiia,
L I Ol'binskaia, and
M A Rybakov, and
Zh M Sizova
March 1988,
Kardiologiia,
L I Ol'binskaia, and
M A Rybakov, and
Zh M Sizova
January 1993,
Likars'ka sprava,
L I Ol'binskaia, and
M A Rybakov, and
Zh M Sizova
June 1990,
La Radiologia medica,
L I Ol'binskaia, and
M A Rybakov, and
Zh M Sizova
May 1989,
Biulleten' eksperimental'noi biologii i meditsiny,
L I Ol'binskaia, and
M A Rybakov, and
Zh M Sizova
January 1983,
Vrachebnoe delo,
L I Ol'binskaia, and
M A Rybakov, and
Zh M Sizova
April 1986,
Vrachebnoe delo,
L I Ol'binskaia, and
M A Rybakov, and
Zh M Sizova
January 1990,
Farmakologiia i toksikologiia,
L I Ol'binskaia, and
M A Rybakov, and
Zh M Sizova
June 1988,
Vrachebnoe delo,
L I Ol'binskaia, and
M A Rybakov, and
Zh M Sizova
April 1981,
Acta anaesthesiologica Scandinavica,
